ALPMY
Price
$11.05
Change
-$0.02 (-0.18%)
Updated
Sep 26 closing price
Capitalization
19.79B
32 days until earnings call
AZNCF
Price
$146.16
Change
-$3.59 (-2.40%)
Updated
Sep 26 closing price
Capitalization
228.48B
Interact to see
Advertisement

ALPMY vs AZNCF

Header iconALPMY vs AZNCF Comparison
Open Charts ALPMY vs AZNCFBanner chart's image
Astellas Pharma
Price$11.05
Change-$0.02 (-0.18%)
Volume$126.21K
Capitalization19.79B
AstraZeneca
Price$146.16
Change-$3.59 (-2.40%)
Volume$944
Capitalization228.48B
ALPMY vs AZNCF Comparison Chart in %
Loading...
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMY vs. AZNCF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMY is a Hold and AZNCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (ALPMY: $11.05 vs. AZNCF: $146.16)
Brand notoriety: ALPMY and AZNCF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMY: 127% vs. AZNCF: 21%
Market capitalization -- ALPMY: $19.79B vs. AZNCF: $228.48B
ALPMY [@Pharmaceuticals: Major] is valued at $19.79B. AZNCF’s [@Pharmaceuticals: Major] market capitalization is $228.48B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $649.52B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMY’s FA Score shows that 1 FA rating(s) are green whileAZNCF’s FA Score has 1 green FA rating(s).

  • ALPMY’s FA Score: 1 green, 4 red.
  • AZNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, AZNCF is a better buy in the long-term than ALPMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMY’s TA Score shows that 2 TA indicator(s) are bullish while AZNCF’s TA Score has 4 bullish TA indicator(s).

  • ALPMY’s TA Score: 2 bullish, 5 bearish.
  • AZNCF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AZNCF is a better buy in the short-term than ALPMY.

Price Growth

ALPMY (@Pharmaceuticals: Major) experienced а -1.69% price change this week, while AZNCF (@Pharmaceuticals: Major) price change was -5.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.20%. For the same industry, the average monthly price growth was -0.44%, and the average quarterly price growth was +12.50%.

Reported Earning Dates

ALPMY is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.20% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZNCF($228B) has a higher market cap than ALPMY($19.8B). ALPMY has higher P/E ratio than AZNCF: ALPMY (58.21) vs AZNCF (27.53). ALPMY YTD gains are higher at: 14.389 vs. AZNCF (12.431). ALPMY has higher annual earnings (EBITDA): 270B vs. AZNCF (16.8B). ALPMY has more cash in the bank: 329B vs. AZNCF (7.11B). AZNCF has less debt than ALPMY: AZNCF (32.8B) vs ALPMY (927B). ALPMY has higher revenues than AZNCF: ALPMY (1.77T) vs AZNCF (56.5B).
ALPMYAZNCFALPMY / AZNCF
Capitalization19.8B228B9%
EBITDA270B16.8B1,607%
Gain YTD14.38912.431116%
P/E Ratio58.2127.53211%
Revenue1.77T56.5B3,136%
Total Cash329B7.11B4,629%
Total Debt927B32.8B2,826%
FUNDAMENTALS RATINGS
ALPMY vs AZNCF: Fundamental Ratings
ALPMY
AZNCF
OUTLOOK RATING
1..100
6484
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
21
Undervalued
PROFIT vs RISK RATING
1..100
10058
SMR RATING
1..100
10046
PRICE GROWTH RATING
1..100
5259
P/E GROWTH RATING
1..100
9680
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMY's Valuation (5) in the null industry is in the same range as AZNCF (21). This means that ALPMY’s stock grew similarly to AZNCF’s over the last 12 months.

AZNCF's Profit vs Risk Rating (58) in the null industry is somewhat better than the same rating for ALPMY (100). This means that AZNCF’s stock grew somewhat faster than ALPMY’s over the last 12 months.

AZNCF's SMR Rating (46) in the null industry is somewhat better than the same rating for ALPMY (100). This means that AZNCF’s stock grew somewhat faster than ALPMY’s over the last 12 months.

ALPMY's Price Growth Rating (52) in the null industry is in the same range as AZNCF (59). This means that ALPMY’s stock grew similarly to AZNCF’s over the last 12 months.

AZNCF's P/E Growth Rating (80) in the null industry is in the same range as ALPMY (96). This means that AZNCF’s stock grew similarly to ALPMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMYAZNCF
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 7 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
55%
MACD
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
62%
Bearish Trend 3 days ago
54%
Advances
ODDS (%)
Bullish Trend 21 days ago
65%
Bullish Trend 7 days ago
66%
Declines
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 5 days ago
49%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMHG51.150.10
+0.20%
Prime Meridian Holding Co.
PBNNF0.25N/A
N/A
PT Bank Negara Indonesia TBK
XTEPY74.51N/A
N/A
Xtep International Holdings Ltd.
PLMUF11.02N/A
N/A
Plum Acquisition Corp. III
GTHP0.24-0.02
-5.88%
Guided Therapeutics, Inc.

ALPMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMY has been loosely correlated with ALPMF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMY jumps, then ALPMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMY
1D Price
Change %
ALPMY100%
-0.16%
ALPMF - ALPMY
37%
Loosely correlated
+0.91%
OPHLY - ALPMY
32%
Poorly correlated
+1.60%
OTSKY - ALPMY
21%
Poorly correlated
-2.51%
BAYRY - ALPMY
13%
Poorly correlated
+0.25%
ABBV - ALPMY
12%
Poorly correlated
+0.95%
More

AZNCF and

Correlation & Price change

A.I.dvisor tells us that AZNCF and BAYRY have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AZNCF and BAYRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZNCF
1D Price
Change %
AZNCF100%
-2.40%
BAYRY - AZNCF
20%
Poorly correlated
+0.25%
AZN - AZNCF
16%
Poorly correlated
+0.31%
ABBV - AZNCF
9%
Poorly correlated
+0.95%
ALPMY - AZNCF
9%
Poorly correlated
-0.16%
ALPMF - AZNCF
7%
Poorly correlated
+0.91%
More